Brian Tanquilut

Q: What is Brian Tanquilut's success rate?

Brian Tanquilut currently has a success rate of 76.68978108668216.

Q: What is the average return of Brian Tanquilut's calls?

Their stock ratings have generated an average return of 15.202353949807485.

Jefferies | Healthcare

Brian Tanquilut is an analyst from Jefferies specializing in the Healthcare sector. Ranked #2077 out of 4655 analysts, they have issued 21 stock ratings with a success rate of 76.69% and an average return of 15.20%.

Brian Tanquilut has a well-established track record, with 21 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 76.69% and an average return of 15.20%, underscoring their expertise and ability to identify winning opportunities for investors.

#2077

Out of 4655

Total Ratings

+76.69%

Success Rate

+15.20%

Average Return

Recent Ratings Analysis

DOCS

Hold

May 14, 2026

Target

$19.00

Current

$18.01

Performance

0.00%

Brian Tanquilut rated DOCS as Hold on May 14, 2026, setting a price target of 19. The Hold stance appears justified, as shares hovered around 18.01 with a 0.00% move.

GRDN

Buy

Mar 30, 2026

Target

$44.00

Current

$36.27

Performance

-2.63%

On Mar 30, 2026, GRDN was given a Buy rating by Brian Tanquilut, with a target price of 44. The stock traded sideways with a -2.63% move, keeping the bullish thesis unresolved.

USPH

Buy

Mar 10, 2026

Target

$102.00

Current

$65.09

Performance

-18.63%

USPH received a Buy rating from Brian Tanquilut on Mar 10, 2026, aiming for 102. The rating hasn’t played out as hoped, with the stock trading 18.63% below expectations.

ODD

Hold

Feb 25, 2026

Target

$64.00

Current

$12.54

Performance

-14.93%

On Feb 25, 2026, Brian Tanquilut published a Hold outlook on ODD, with a target of 64. Weakness in the stock, now at 12.54, supported the conservative rating.

EHAB

Hold

Feb 23, 2026

Target

$13.80

Current

$13.80

Performance

1.47%

Brian Tanquilut on Feb 23, 2026 assigned EHAB a Hold rating, with a price target of 13.8. The Hold stance reflected consolidation, as shares held near 13.8.

THC

Buy

Feb 12, 2026

Target

$265.00

Current

$198.55

Performance

-14.51%

On Feb 12, 2026, Brian Tanquilut reaffirmed THC with a Buy rating, targeting 265. Shares slid 14.51% despite the recommendation, highlighting downside risks.

HCA

Buy

Jan 28, 2026

Target

$590.00

Current

$432.70

Performance

-11.91%

HCA was rated Buy by Brian Tanquilut on Jan 28, 2026, with a price objective of 590. This case shows how bullish projections can fail, with the stock now below 432.7.

COR

Buy

Jan 22, 2026

Target

$440.00

Current

$261.11

Performance

-25.92%

On Jan 22, 2026, Brian Tanquilut initiated coverage on COR with a Buy rating and target of 440. The Buy call has yet to be validated as shares remain 178.89 away from the target.

ACHC

Hold

Jan 22, 2026

Target

$15.00

Current

$26.80

Performance

76.90%

Brian Tanquilut issued a Hold recommendation for ACHC on Jan 22, 2026, price target set at 15. A neutral call gave way to stronger-than-expected performance, closing in on 15.

CHE

Hold

Jan 22, 2026

Target

$475.00

Current

$426.21

Performance

-4.17%

On Jan 22, 2026, CHE was evaluated by Brian Tanquilut, who gave a Hold rating and target of 475. Hold sentiment was validated by subdued trading with no breakout beyond 426.21.

LMRI

Buy

Jan 05, 2026

Target

$23.00

Current

$7.21

Performance

-57.16%

Brian Tanquilut rated LMRI as Buy on Jan 05, 2026, setting a price target of 23. The stock has underperformed, dropping 57.16% despite the bullish target of 23.

AVAH

Buy

Oct 28, 2025

Target

$12.50

Current

$7.44

Performance

-24.16%

On Oct 28, 2025, AVAH was given a Buy rating by Brian Tanquilut, with a target price of 12.5. Despite the Buy call, shares fell from 7.44 to 7.44, challenging the optimistic stance.

PNTG

Buy

Oct 24, 2025

Target

$30.00

Current

$36.90

Performance

46.20%

PNTG received a Buy rating from Brian Tanquilut on Oct 24, 2025, aiming for 30. Momentum has favored the Buy call, with shares climbing from 36.9 to 36.9, rewarding those who trusted the recommendation.

MCK

Buy

Oct 14, 2025

Target

$900.00

Current

$747.23

Performance

-4.43%

On Oct 14, 2025, Brian Tanquilut published a Buy outlook on MCK, with a target of 900. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 747.23.

CYH

Hold

Jul 24, 2025

Target

$3.00

Current

$2.90

Performance

0.00%

Brian Tanquilut on Jul 24, 2025 assigned CYH a Hold rating, with a price target of 3. The Hold stance reflected consolidation, as shares held near 2.9.

CVS

Buy

Jun 30, 2025

Target

$80.00

Current

$97.15

Performance

40.84%

On Jun 30, 2025, Brian Tanquilut reaffirmed CVS with a Buy rating, targeting 80. The recommendation was supported by strong follow-through as the stock rose from 97.15 to 97.15.

CAH

Buy

Feb 05, 2025

Target

$150.00

Current

$194.38

Performance

52.51%

CAH was rated Buy by Brian Tanquilut on Feb 05, 2025, with a price objective of 150. A bullish response from the market helped close the gap of -44.38 to the target.

OPCH

Buy

Jan 23, 2025

Target

$35.00

Current

$19.95

Performance

-33.50%

On Jan 23, 2025, Brian Tanquilut initiated coverage on OPCH with a Buy rating and target of 35. The Buy call has yet to be validated as shares remain 15.05 away from the target.

RDNT

Buy

Jan 15, 2025

Target

$80.00

Current

$53.43

Performance

-13.46%

Brian Tanquilut issued a Buy recommendation for RDNT on Jan 15, 2025, price target set at 80. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

LH

Buy

Dec 10, 2024

Target

$275.00

Current

$254.02

Performance

8.31%

On Dec 10, 2024, LH was evaluated by Brian Tanquilut, who gave a Buy rating and target of 275. This case illustrates how a timely bullish rating can translate into tangible gains of 8.31%.

BKD

Buy

Oct 16, 2024

Target

$8.00

Current

$13.21

Performance

97.75%

Brian Tanquilut rated BKD as Buy on Oct 16, 2024, setting a price target of 8. The call has proven timely, with shares rising 97.75% toward the price target of 8.

MODV

Hold

Sep 13, 2024

Target

$14.00

Current

$0.43

Performance

-96.94%

On Sep 13, 2024, MODV was given a Hold rating by Brian Tanquilut, with a target price of 14. The rating provided protection from downside risk as the stock fell to 0.4319.

Frequency Asked Questions

Who is Brian Tanquilut?

Brian Tanquilut is an analyst from Jefferies specializing in the Healthcare sector.

What is Brian Tanquilut's success rate?

Brian Tanquilut currently has a success rate of +76.69%.

How many ratings has Brian Tanquilut issued?

Brian Tanquilut has issued 21 stock ratings so far.

What is the average return of Brian Tanquilut's calls?

Their stock ratings have generated an average return of +15.20%.

What is Brian Tanquilut's ranking?

Brian Tanquilut is ranked #2077 out of 4655 analysts.

What types of ratings does Brian Tanquilut give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Brian Tanquilut?

You can follow Brian Tanquilut by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Brian Tanquilut?

Their latest rating was a Hold on DOCS issued on 2026-05-14.